Back to Search
Start Over
Pueraria montana (Kudzu vine) Ameliorate the Inflammation and Oxidative Stress against Fe-NTA Induced Renal Cancer.
- Source :
-
Journal of oleo science [J Oleo Sci] 2022 Sep 30; Vol. 71 (10), pp. 1481-1492. Date of Electronic Publication: 2022 Sep 09. - Publication Year :
- 2022
-
Abstract
- Renal tissue plays a crucial function in maintaining homeostasis, making it vulnerable to xenobiotic toxicity. Pueraria montana has more beneficial potential against the various diseases and has long history used as a traditional Chinese medicine. But its effect against the renal cancer not scrutinize. The goal of this study is to see if Pueraria montana can protect rats from developing kidney tumors caused by diethylnitrosamine (DEN) and ferric nitrite (Fe-NTA). Wistar rats was selected for the current study and DEN (use as an inducer) and Fe-NTA (promoter) for induction the renal cancer. For 22 weeks, the rats were given orally Pueraria montana (12.5, 25, and 50 mg/kg) treatment. At regular intervals, the body weight and food intake were calculated. The rats were macroscopically evaluated for identification of cancer in the renal tissue. The renal tumor makers, renal parameters, antioxidant enzymes, phase I and II enzymes, inflammatory cytokines and mediators were estimated at end of the experimental study. Pueraria montana treated rats displayed the suppression of renal tumors, incidence of the tumors along with suppression of tumor percentage. Pueraria montana treated rats significantly (p < 0.001) increased body weight and suppressed the renal weight and food intake. It also reduced the level of renal tumor marker ornithine decarboxylase (ODC) and [3H] thymidine incorporation along with suppression of renal parameter such as uric acid, blood urea nitrogen (BUN), urea and creatinine. Pueraria montana treatment significantly (p < 0.001) altered the level of phase enzymes and antioxidant. Pueraria montana treatment significantly (p < 0.001) repressed the level of tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), interleukin-6 (IL-6) and improved the level of interleukin-10 (IL-10). Pueraria montana treatment suppressed the level of prostaglandin (PGE <subscript>2</subscript> ), cyclooxygenase-2 (COX-2), nuclear kappa B factor (NF-κB) and transforming growth factor beta 1 (TGF-β1). Pueraria montana suppressed the inflammatory necrosis, size the bowman capsules in the renal histopathology. Pueraria montana exhibited the chemoprotective effect via dual mechanism such as suppression of inflammatory reaction and oxidative stress.
- Subjects :
- Animals
Antioxidants pharmacology
Biomarkers, Tumor metabolism
Biomarkers, Tumor pharmacology
Body Weight
Creatinine pharmacology
Cyclooxygenase 2 metabolism
Diethylnitrosamine pharmacology
Ferric Compounds
Inflammation drug therapy
Interleukin-10
Interleukin-1beta metabolism
Interleukin-6 metabolism
NF-kappa B metabolism
Nitrilotriacetic Acid analogs & derivatives
Nitrites pharmacology
Ornithine Decarboxylase metabolism
Ornithine Decarboxylase pharmacology
Oxidative Stress
Prostaglandins
Prostaglandins E metabolism
Prostaglandins E pharmacology
Rats
Rats, Wistar
Thymidine metabolism
Thymidine pharmacology
Transforming Growth Factor beta1 metabolism
Transforming Growth Factor beta1 pharmacology
Tumor Necrosis Factor-alpha metabolism
Urea
Uric Acid pharmacology
Xenobiotics pharmacology
Kidney Neoplasms chemically induced
Kidney Neoplasms drug therapy
Kidney Neoplasms metabolism
Pueraria metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1347-3352
- Volume :
- 71
- Issue :
- 10
- Database :
- MEDLINE
- Journal :
- Journal of oleo science
- Publication Type :
- Academic Journal
- Accession number :
- 36089399
- Full Text :
- https://doi.org/10.5650/jos.ess22151